Dermatologic and Ophthalmic Drugs Advisory Committee

Results: 196



#Item
1Missing Data Issues in Regulatory Clinical Trials Lisa M. LaVange, PhD Office of Biostatistics OTS/CDER/US FDA

Missing Data Issues in Regulatory Clinical Trials Lisa M. LaVange, PhD Office of Biostatistics OTS/CDER/US FDA

Add to Reading List

Source URL: www.jpma.or.jp

Language: English - Date: 2015-02-24 20:15:37
2Federal Register / Vol. 80, No[removed]Friday, April 3, [removed]Notices trading in a range from 0 to 1⁄4 percent. The Committee directs the Desk to undertake open market operations as necessary to maintain such conditions

Federal Register / Vol. 80, No[removed]Friday, April 3, [removed]Notices trading in a range from 0 to 1⁄4 percent. The Committee directs the Desk to undertake open market operations as necessary to maintain such conditions

Add to Reading List

Source URL: www.gpo.gov

Language: English - Date: 2015-04-03 10:00:56
3FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and the Ophthalmic Devices Panel of the Medical Devices

FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and the Ophthalmic Devices Panel of the Medical Devices

Add to Reading List

Source URL: www.fda.gov

Language: English
4FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and the Ophthalmic Devices Panel of the Medical Devices

FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and the Ophthalmic Devices Panel of the Medical Devices

Add to Reading List

Source URL: www.fda.gov

Language: English
5CARDIOVASCULAR AND RENAL DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

CARDIOVASCULAR AND RENAL DRUGS ADVISORY COMMITTEE MEMBERS (Voting)

Add to Reading List

Source URL: www.fda.gov

Language: English
6Dermatologic and Ophthalmic Drugs Advisory Committee

Dermatologic and Ophthalmic Drugs Advisory Committee

Add to Reading List

Source URL: www.fda.gov

Language: English
7Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Afternoon Session FDA Introductory Remarks Kendall A. Marcus, MD

Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Afternoon Session FDA Introductory Remarks Kendall A. Marcus, MD

Add to Reading List

Source URL: www.fda.gov

Language: English
8Dermatologic and Ophthalmic Drugs Advisory Committee  Meeting Background Materials Meeting Package Dermatologic and Ophthalmic Drugs Advisory Committee

Dermatologic and Ophthalmic Drugs Advisory Committee Meeting Background Materials Meeting Package Dermatologic and Ophthalmic Drugs Advisory Committee

Add to Reading List

Source URL: www.fda.gov

Language: English
9February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee - Webcast Recording The Center for Drug Ev

February 24, 2015, Joint Meeting of the Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) and Ophthalmic Devices Panel (ODP) of the Medical Devices Advisory Committee - Webcast Recording The Center for Drug Ev

Add to Reading List

Source URL: www.fda.gov

Language: English
10FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting FDA White Oak Campus, 10903 New Hampshire Avenue Building 31 Conferen

FOOD AND DRUG ADMINISTRATION (FDA) Center for Drug Evaluation and Research (CDER) Dermatologic and Ophthalmic Drugs Advisory Committee (DODAC) Meeting FDA White Oak Campus, 10903 New Hampshire Avenue Building 31 Conferen

Add to Reading List

Source URL: www.fda.gov

Language: English